Eli Lilly and Company: all 2,262 studies
Page 19 of 23. Open to participants first (177), then studies with results posted, then the rest; newest registration first within each.
- ADVM-022 Intravitreal Gene Therapy for Wet AMDCompletedNCT03748784Phase 1
- A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus (T1D)CompletedNCT03743285Not applicable
- A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHLCompletedNCT03740529Phase 1/2
- A Study of LY3090106 in Japanese and Caucasian Healthy ParticipantsCompletedNCT03736772Phase 1
- A Study of LY3374849 in Healthy ParticipantsCompletedNCT03726125Phase 1
- A Study of LY3372993 in Healthy Participants and Participants With Alzheimer's Disease (AD)CompletedNCT03720548Phase 1
- A Safety Study of LY3462817 in Healthy ParticipantsCompletedNCT03715192Phase 1
- A Study of LY3361237 in Healthy ParticipantsCompletedNCT03695198Phase 1
- Study of LY3154207 in Healthy ParticipantsCompletedNCT03616795Phase 1
- A Study of LY3209590 in Japanese Participants With Type 2 DiabetesCompletedNCT03603704Phase 1
- A Study of LY3322207 in Healthy Participants and in Participants With Hypertension (High Blood Pressure)TerminatedNCT03590860Phase 1
- A Study of the Effect of a Disease-Specific Migraine Smart Phone Application (App) on Participant CareCompletedNCT03559088Not applicable
- An Expanded Access Program for AM0010 (Pegilodecakin)No longer availableNCT03554434
- A Study of Lanabecestat in Participants With Severe Kidney Impairment Compared to Healthy ParticipantsWithdrawnNCT03545087Phase 1
- A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)Active, not recruitingNCT03519945Phase 3
- A Study of Lanabecestat in Healthy Female Participants Taking Oral ContraceptiveWithdrawnNCT03506399Phase 1
- A Study of LY3314814 in Participants With Liver ImpairmentWithdrawnNCT03499041Phase 1
- A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic MigraineActive, not recruitingNCT03432286Phase 3
- A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)CompletedNCT03367390Phase 1
- A Study of LY3209590 in Participants With Type 2 DiabetesCompletedNCT03367377Phase 1
- A Study of LY3381916 Alone or in Combination With LY3300054 in Participants With Solid TumorsTerminatedNCT03343613Phase 1
- A Study of LY3375880 in Healthy ParticipantsCompletedNCT03343587Phase 1
- A Study of Multiple Doses of LY3305677 in Healthy ParticipantsCompletedNCT03325387Phase 1
- A Study to Assess the Amount of LY3074828 That Gets Into the Body When Given With LY9999QS, in Healthy ParticipantsCompletedNCT03220126Phase 1
- A Study of LY3002815 in Healthy ParticipantsTerminatedNCT03148431Phase 1
- A Study of LY3325656 in Healthy Participants and Participants With Type 2 DiabetesCompletedNCT03115099Phase 1
- A Study of LY3321367 Alone or With LY3300054 in Participants With Advanced Relapsed/Refractory Solid TumorsCompletedNCT03099109Phase 1
- A Study of Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic CancerCompletedNCT03027284Phase 1
- A Study of LY3192767 in Healthy ParticipantsCompletedNCT03025009Phase 1
- A Study of LY3305677 in Healthy ParticipantsCompletedNCT02972645Phase 1
- A Study of LY2775240 in Healthy ParticipantsCompletedNCT02963779Phase 1
- A Study Comparing Two Formulations of Insulin Glargine in Healthy ParticipantsCompletedNCT02955953Phase 1
- A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)Active, not recruitingNCT02951598
- A Study of LY3209590 in Healthy Participants and Participants With Type 2 DiabetesCompletedNCT02942914Phase 1
- A Study of Gemcitabine-Carboplatin Plus Necitumumab (LY3012211) in Chemotherapy-Naïve Participants With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)WithdrawnNCT02941601Phase 2
- A Study of LY3200882 in Participants With Solid TumorsActive, not recruitingNCT02937272Phase 1
- Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research TrialsCompletedNCT02918539
- A Study of LY3041658 in Participants With Skin DiseasesCompletedNCT02896868Phase 1
- A Study of Prexasertib (LY2606368) in Combination With Ralimetinib in Participants With Advanced or Metastatic CancerCompletedNCT02860780Phase 1
- A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic CancerCompletedNCT02857270Phase 1
- A Study to Characterize the Cardiac Phenotype of Individuals With Friedreich's Ataxia (CARFA Study)CompletedNCT02840669Not applicable
- A Study of Ramucirumab (LY3009806) in Combination With Weekly Docetaxel in Participants With Stage IV Non-Small Cell Lung CancerWithdrawnNCT02831491Phase 2
- A Study of LY3023414 Formulations and the Effect of FoodCompletedNCT02818335Phase 1
- Expanded Access Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast CancerApproved for marketingNCT02792725
- A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid TumorsCompletedNCT02791334Phase 1
- A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast CancerActive, not recruitingNCT02779751Phase 1
- A Study of Merestinib (LY2801653) in Healthy ParticipantsCompletedNCT02779738Phase 1
- A Study of Prexasertib (LY2606368) in Participants With Advanced CancerCompletedNCT02778126Phase 1
- Study of Galunisertib in Healthy ParticipantsCompletedNCT02752919Phase 1
- A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted AgentsCompletedNCT02745769Phase 1
- A Study of Galunisertib (LY2157299) and Durvalumab (MEDI4736) in Participants With Metastatic Pancreatic CancerCompletedNCT02734160Phase 1
- A Study of a Novel Insulin Lispro Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin PumpsWithdrawnNCT02623478Phase 1
- A Study of a New Type of Insulin in Participants With Type 2 Diabetes on Insulin Injection TherapyWithdrawnNCT02623465Phase 1
- A Study of a New Type of Insulin in Participants With Type 1 Diabetes on Insulin Injection TherapyWithdrawnNCT02623452Phase 1
- A Study of LY3090106 in Participants With Sjögren's Syndrome (SS)CompletedNCT02614716Phase 1
- A Study of LY3154207 on Sleep in Healthy Male ParticipantsCompletedNCT02603861Phase 1
- A Study of LY3200327 in Healthy ParticipantsCompletedNCT02595736Phase 1
- A Study of [¹⁴C]-LY3023414 in Healthy ParticipantsCompletedNCT02575703Phase 1
- A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic MalignanciesCompletedNCT02572687Phase 1
- A Study of LY3154207 in Healthy Participants and Participants With Parkinson's DiseaseCompletedNCT02562768Phase 1
- A Study of Prexasertib (LY2606368) With Chemotherapy and Radiation in Participants With Head and Neck CancerCompletedNCT02555644Phase 1
- A Study of LY3023414 in Japanese Participants With Advanced CancerCompletedNCT02536586Phase 1
- A Study of Prexasertib (LY2606368) in Japanese Participants With Advanced CancersCompletedNCT02514603Phase 1
- 18F-AV-1451 PET Imaging in TBIWithdrawnNCT02512029Phase 1
- The Forteo Alendronate Comparator TrialCompletedNCT02416271Phase 4
- A Study of LY2801653 in Healthy Participants Who Are Not Able to Have ChildrenCompletedNCT02370485Phase 1
- A Study of LY3154207 in Healthy ParticipantsCompletedNCT02365571Phase 1
- Ramucirumab Use in Combination With Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma; Temporary Authorization for Use (ATU) in FranceApproved for marketingNCT02307812
- A Study of Galunisertib on the Immune System in Participants With CancerCompletedNCT02304419Phase 1
- A Study of LY2157299 in Participants With Unresectable Hepatocellular Cancer (HCC)CompletedNCT02240433Phase 1
- A Study of LY2157299 in Participants With Pancreatic Cancer That is Advanced or Has Spread to Another Part of the BodyCompletedNCT02154646Phase 1
- Safety Study of LY3041658 in Healthy ParticipantsCompletedNCT02148627Phase 1
- Safety Study to Evaluate LY3114062 in Participants With Inflammatory ArthritisCompletedNCT02144272Phase 1
- A Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced CancerCompletedNCT02124148Phase 1
- A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes MellitusWithdrawnNCT02106364Phase 3
- International Expanded Access Program to Provide Ramucirumab for the Treatment of Metastatic Gastric CancerApproved for marketingNCT02065765
- A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has SpreadActive, not recruitingNCT02057133Phase 1
- Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese PhysiciansWithdrawnNCT02029547Not applicable
- A Study of LY3108743 in Healthy Participants and Participants With Type 2 DiabetesCompletedNCT01995656Phase 1
- A Safety and Efficacy Study of DRM02 in Subjects With RosaceaCompletedNCT01993446Phase 2
- A Safety and Efficacy Study of DRM02 in Subjects With Plaque PsoriasisCompletedNCT01993433Phase 2
- A Safety and Efficacy of DRM02 in Subjects With Atopic DermatitisCompletedNCT01993420Phase 2
- A Study of LY2801653 in Healthy ParticipantsCompletedNCT01981408Phase 1
- A Study of LY2157299 in Healthy ParticipantsCompletedNCT01965808Phase 1
- A Study of LY3090106 in Healthy Participants and Participants With Rheumatoid Arthritis (RA)CompletedNCT01925157Phase 1
- A Study of LY2875358 in Participants With Non-Small Cell Lung Cancer With Activating Epidermal Growth Factor Receptor MutationsCompletedNCT01897480Phase 2
- A Study of LY2875358 in Participants With MET Positive, Advanced Gastric CancerCompletedNCT01874938Phase 2
- A Study of LY2605541 and Insulin Lispro Mixture in Healthy ParticipantsCompletedNCT01871493Phase 1
- Study of Ixekizumab in Participants With Active Ankylosing Spondylitis (AS)WithdrawnNCT01870284Phase 3
- Open-label Safety and Tolerability Study of LTS-PDT in Healthy VolunteersCompletedNCT01830764Phase 1
- A Study of LY3045697 After Multiple Oral Dosing in Healthy ParticipantsCompletedNCT01821703Phase 1
- A Study of LY2624803 in Participants With Transient InsomniaCompletedNCT01779830Phase 1
- A Study of LY3045697 in Healthy ParticipantsCompletedNCT01750853Phase 1
- A Study of LY2157299 Monohydrate in Healthy VolunteersCompletedNCT01746004Phase 1
- A Phase 0, Open Label, Multi-center Exploratory and Safety Study of [F-18]T807TerminatedNCT01733355Early Phase 1
- Compassionate Use Protocol for the Treatment of Autoinflammatory SyndromesApproved for marketingNCT01724580
- A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808TerminatedNCT01723488Early Phase 1
- Study of LY2157299 in Japanese Participants With CancerCompletedNCT01722825Phase 1
- Quantitative 18F-AV-133 PET Imaging in Subjects With Diabetes and Healthy ControlsCompletedNCT01710371Phase 1
- A Study of LY2940680 in Pediatric Medulloblastoma or RhabdomyosarcomaWithdrawnNCT01697514Phase 1